Teijin Limited (帝人株式会社) is a diversified Japanese multinational corporation engaged in the development, manufacture, and sale of advanced materials and healthcare products.
Founded in 1918, the company initially focused on synthetic fibers and has grown into a global leader in high-performance materials, including aramid fibers (such as Twaron and Technora under the Teijin Aramid brand), carbon fibers, composites, resins, films, sheets, and flame retardants. These products serve key industries including automotive, aerospace, electronics, construction, and safety protection.
The healthcare segment encompasses pharmaceuticals for bone, joint, respiratory, and metabolic diseases, as well as medical devices and home healthcare services, where it holds Japan's leading market position in CPAP devices for sleep therapy.
Headquartered in Tokyo with operations also in Osaka, the Teijin Group comprises 126 companies (43 in Japan and 83 overseas) and employs approximately 15,689 people as of March 2026. It maintains a strong international presence with over 50% of revenue from overseas markets across Asia, the Americas, and Europe.
Listed on the Tokyo Stock Exchange (ticker 3401) and a constituent of the Nikkei 225, Teijin operates as a technology-driven holding company committed to sustainable innovation under its purpose of "Pioneering solutions together for a healthy planet."
Official website: teijin.com
To provide comprehensive coverage, we aggregate data and news under the name Teijin, encompassing the following company names, divisions, and related entities:
Teijin Aramid, Teijin Ltd., Teijin Group, 帝人株式会社, and Teijin Kabushiki-gaisha.
This list encompasses current and former names, alternate names, and key divisions associated with Teijin, ensuring you can easily find all relevant information under a single, unified profile.
